We found that LPIN1 expression correlates with measures of skeletal muscle and hepatic insulin sensitivity and inversely correlates with hepatic de novo lipogenesis (DNL), a sensitive marker of hepatic insulin resistance and a characteristic of MASLD (11). The gene discussed is INS; the disease is Insulin resistance.